Hypothyroidism Market -
Overview
The Global Hypothyroidism Market is expected to grow at a
CAGR of 3.7% during the forecast period. Increasing prevalence of
hypothyroidism, advancements in healthcare facilities, and favorable
reimbursement and funding policies are expected to drive the market growth over
the forecast period. According to information suggested by the 2017 guideline
of the American Thyroid Association (ATA), 20 million Americans had some form
of hypothyroidism disorder. However, side-effects related to available
therapeutics can restrain the market growth over the assessment period.
Hypothyroidism Market
- Key Players
Some of the prominent players in the global hypothyroidism
market are Pfizer Inc., AbbVie Inc., Merck & Co., Inc., ALLERGAN, Mylan
N.V., Erfa Canada Inc, Novartis AG, GlaxoSmithKline plc, RLC Labs and others
Hypothyroidism Market -
Segmentation
The Global Hypothyroidism Market has been segmented into
type of hypothyroidism, diagnosis & treatment, route of administration and
end user.The market, on the basis of type of hypothyroidism, has been segmented
into primary hypothyroidism, secondary hypothyroidism, and tertiary
hypothyroidism.The Global market, on the basis of diagnosis & treatment,
has been segmented into diagnosis and treatment. The diagnosis segment is
further classified as physical examination, blood tests, imaging scan, and others.
The treatment segment is further classified as levothyroxine sodium,
liothyronine, and natural desiccated thyroid (NDT).
The levothyroxine sodium is expected to hold the largest
market share owing to the growing prevalence of thyroid disorder, and
effectiveness of drug. The Synthroid drug by Abbvie holds the major share in
the US market. In 2016, Abbvie Inc. generated revenue of 763 USD million with
Synthroid drug in US only.The Global Hypothyroidism Market, by route of
administration, has been segmented into oral, intravenous, and others. The
Global market, on the basis of end users, has been segmented into hospitals,
clinics, research & academic institutes and others.
Hypothyroidism Market -
Regional Analysis
Geographically, the Americas is expected to dominate the
global market owing to the increased prevalence of hypothyroidism. According to
the American Thyroid Association, more than 12% of the US population develops a
thyroid disorder during their lifetime. Europe is expected to hold the second
largest position in the global market owing to the favorable reimbursement and
funding policies. According to the Thyroid UK in 2016/2017, the National Health
Service (NHS), England spent more than ~USD 42 Million on liothyronine (a drug
for the treatment of hypothyroidism). Asia-Pacific is expected to be the
fastest growing market owing to the presence of a large patient pool and
improving healthcare infrastructure. According to a study published in the
Journal of Clinical and Diagnostic Research in 2016, nearly 42 Million people
residing in the country suffer from thyroid disorders. This prevalence of
thyroid, consequently, results in an increased demand for therapeutic. This is
projected to drive market growth. Moreover, the Middle East and Africa region
is expected to account for the least market share in the global market.
Major Table of
Content at “Hypothyroidism Market Research Report – Global Forecast till 2023’
Chapter 1. Report
Prologue
Chapter 2. Market
Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research
Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market
Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
TOC Continued……...!
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
No comments:
Post a Comment